A carregar...
Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
In order to facilitate long-term treatment decisions, we aimed to define biomarkers defining the probability of receiving second-line (SL) targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC) based on their characteristics present at first-line TT initiation. We analysed 152...
Na minha lista:
| Publicado no: | Med Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5940724/ https://ncbi.nlm.nih.gov/pubmed/29737510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-018-1148-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|